Does XTANDI Cause Mobility decreased? 5 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Mobility decreased have been filed in association with XTANDI. This represents 0.4% of all adverse event reports for XTANDI.
5
Reports of Mobility decreased with XTANDI
0.4%
of all XTANDI reports
0
Deaths
1
Hospitalizations
How Dangerous Is Mobility decreased From XTANDI?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XTANDI. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does XTANDI Cause?
Malignant neoplasm progression (235)
Death (234)
Fatigue (162)
Drug ineffective (158)
Prostatic specific antigen increased (94)
Nausea (69)
Asthenia (62)
Decreased appetite (56)
Dizziness (52)
Diarrhoea (51)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)